FIELD: medicine, virology. SUBSTANCE: human blood cells are treated with preparation that blocks binding HIV with cell-target during culturing. Human fetal alpha-fetoprotein at concentration 2-15 mcg/ml culturing medium is used as a preparation. EFFECT: simplified method, decreased cost.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ISOLATION OF ALPHA-FETOPROTEIN FROM THE HUMAN SERUM BLOOD | 1995 |
|
RU2097049C1 |
METHOD AND REMEDY FOR INHIBITING GROWS OF TUMOR CELLS | 1994 |
|
RU2034562C1 |
METHOD OF PRIMARY LIVER CANCER TREATMENT AND KIT FOR PRIMARY LIVER CANCER TREATMENT | 1994 |
|
RU2065307C1 |
METHOD FOR PRODUCTION OF ALPHA-FETOPROTEIN | 2006 |
|
RU2308286C1 |
METHOD FOR PREPARING PREPARATION DRY ALPHA-FETOPROTEIN | 2005 |
|
RU2283131C1 |
CHROMATOGRAPHIC METHOD FOR ISOLATION OF ALFA-FETOPROTEIN | 1996 |
|
RU2094078C1 |
METHOD OF PURIFICATION OF HUMAN ALPHA-FETOPROTEIN | 1994 |
|
RU2074193C1 |
CHROMATOGRAPHIC METHOD FOR ISOLATION OF ALFA-FETOPROTEIN | 1996 |
|
RU2094077C1 |
METHOD FOR PREPARING ALPHA-FETOPROTEIN PREPARATION TABLET | 2005 |
|
RU2319479C2 |
MEDICATION COMPOSITION AND METHOD OF ITS OBTAINING FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B OR C AND AIDS | 2010 |
|
RU2440133C2 |
Authors
Dates
1998-07-10—Published
1995-07-19—Filed